Related Experiment Video
Updated: May 8, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
Signatures of mutational processes in human cancer
Ludmil B Alexandrov1, Serena Nik-Zainal, David C Wedge
1Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Abstract:
All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.
Insights
Cancer development is driven by somatic mutations. This study identified over 20 distinct mutational signatures across 7,042 cancers, revealing diverse biological processes and potential therapeutic targets.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Somatic mutations are the fundamental cause of all cancers.
- Understanding the biological processes that generate these mutations is crucial but limited.
- Cancer genomes contain signatures reflecting the mutational processes involved.
Purpose of the Study:
- To analyze a large dataset of cancer mutations to identify and characterize mutational signatures.
- To explore the origins and associations of these signatures with clinical and etiological factors.
- To investigate localized hypermutation events ('kataegis') in cancer genomes.
Main Methods:
- Analysis of 4,938,362 mutations from 7,042 cancer samples.
- Extraction and classification of distinct mutational signatures.
- Correlation of signatures with patient age, mutagenic exposures, and DNA repair defects.
Main Results:
- Identification of over 20 distinct mutational signatures.
- Discovery of signatures associated with APOBEC enzymes, patient age, and DNA maintenance.
- Observation of cryptic signatures and localized hypermutation (kataegis) in various cancer types.
- Demonstration of diverse mutational processes underlying cancer development.
Conclusions:
- The study reveals a wide spectrum of mutational processes contributing to cancer.
- Mutational signatures offer insights into cancer etiology, prevention, and treatment strategies.
- Further research into cryptic signatures and kataegis could uncover novel therapeutic avenues.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

